Literature DB >> 22555380

Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone.

Amit Wani1, Elayaraja Muthuswamy, Galbokka H Layan Savithra, Guangzhao Mao, Stephanie Brock, David Oupický.   

Abstract

PURPOSE: To investigate the effect of surface functionalization of mesoporous silica nanoparticles (MSN) on crystallization, loading, release and activity of mitoxantrone (MTX).
METHODS: Thiol-, amine-, and mixed thiol/amine-functionalized MSN were synthesized and characterized by electron microscopy, thermogravimetry, surface area analysis, elemental analysis and zeta potential. MTX loading and release kinetics were determined in phosphate and acetate buffers (pH 7.4 and 4.5). The crystalline state of MTX in MSN was determined by differential scanning calorimetry and X-ray diffraction. Cytotoxicity and activity of MTX loaded MSN were determined by MTS assay in MDA-MB-231 cells.
RESULTS: Our results demonstrate that loading of MTX depends strongly on the type of surface functional groups in MSN. Thiol-MSN showed the highest MTX loading (18 % w/w) when compared with thiol/amine-MSN (6 % w/w) and amine-MSN (1 % w/w). MTX release was strongly dependent on the pH of the release medium and the type of surface functional group. MTX was found in the amorphous form when loaded in thiol-functionalized MSN. No significant effect of surface modification of MSN on particle toxicity was observed. MTX loaded in MSN exhibited comparable anticancer activity in vitro as free MTX.
CONCLUSION: Surface modifications of MSN have significant effect on MTX crystallization and release behavior.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555380     DOI: 10.1007/s11095-012-0766-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  A molecular understanding of mitoxantrone-DNA adduct formation: effect of cytosine methylation and flanking sequences.

Authors:  Belinda S Parker; Trevor Buley; Ben J Evison; Suzanne M Cutts; Greg M Neumann; Magdy N Iskander; Don R Phillips
Journal:  J Biol Chem       Date:  2004-02-12       Impact factor: 5.157

2.  Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries.

Authors:  Joakim Riikonen; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto
Journal:  Langmuir       Date:  2009-06-02       Impact factor: 3.882

Review 3.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Authors:  Igor I Slowing; Juan L Vivero-Escoto; Chia-Wen Wu; Victor S-Y Lin
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

4.  pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.

Authors:  Faheem Muhammad; Mingyi Guo; Wenxiu Qi; Fuxing Sun; Aifei Wang; Yingjie Guo; Guangshan Zhu
Journal:  J Am Chem Soc       Date:  2011-05-23       Impact factor: 15.419

5.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

Authors:  Cheng-Yu Lai; Brian G Trewyn; Dusan M Jeftinija; Ksenija Jeftinija; Shu Xu; Srdija Jeftinija; Victor S-Y Lin
Journal:  J Am Chem Soc       Date:  2003-04-16       Impact factor: 15.419

6.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

Authors:  Huan Meng; Min Xue; Tian Xia; Zhaoxia Ji; Derrick Y Tarn; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2011-04-27       Impact factor: 15.881

7.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications.

Authors:  Ji-Ho Park; Luo Gu; Geoffrey von Maltzahn; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Nat Mater       Date:  2009-02-22       Impact factor: 43.841

8.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.

Authors:  Alex M Chen; Min Zhang; Dongguang Wei; Dirk Stueber; Oleh Taratula; Tamara Minko; Huixin He
Journal:  Small       Date:  2009-12       Impact factor: 13.281

Review 9.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

10.  Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.

Authors:  Hongli Chen; Wenzhi Yang; Han Chen; Lingrong Liu; Fuping Gao; Xindu Yang; Qian Jiang; Qiqing Zhang; Yinsong Wang
Journal:  Colloids Surf B Biointerfaces       Date:  2009-05-29       Impact factor: 5.268

View more
  14 in total

1.  A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib.

Authors:  Yanzhuo Zhang; Hong Wang; Chuanjun Li; Baoxiang Sun; Yu Wang; Siling Wang; Cunqiang Gao
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

2.  Multifunctional yolk-in-shell nanoparticles for pH-triggered drug release and imaging.

Authors:  Hongyu Chen; Bin Qi; Thomas Moore; Fenglin Wang; Daniel C Colvin; Liurukara D Sanjeewa; John C Gore; Shiou-Jyh Hwu; O Thompson Mefford; Frank Alexis; Jeffrey N Anker
Journal:  Small       Date:  2014-04-19       Impact factor: 13.281

3.  Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.

Authors:  Yanzhuo Zhang; Qinfu Zhao; Wufu Zhu; Lihua Zhang; Jin Han; Qisi Lin; Fengwei Ai
Journal:  Pharm Res       Date:  2015-01-22       Impact factor: 4.200

4.  Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to Near-Infrared Light and Redox Potential as a Theranostic Platform for Cancer Therapy.

Authors:  Bei Cheng; Huacheng He; Tao Huang; Stuart S Berr; Jiang He; Daping Fan; Jiajia Zhang; Peisheng Xu
Journal:  J Biomed Nanotechnol       Date:  2016-03       Impact factor: 4.099

5.  Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.

Authors:  Yang Guo; Ting Zhong; Xiao-Chuan Duan; Shuang Zhang; Xin Yao; Yi-Fan Yin; Dan Huang; Wei Ren; Qiang Zhang; Xuan Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.

Authors:  Dawid Lewandowski; Marta Lewandowska; Piotr Ruszkowski; Anita Pińska; Grzegorz Schroeder
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

7.  Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs.

Authors:  Lihua Zhang; Wufu Zhu; Qisi Lin; Jin Han; Liqun Jiang; Yanzhuo Zhang
Journal:  Int J Nanomedicine       Date:  2015-04-30

8.  SBA-15 Mesoporous Silica Modified with Gallic Acid and Evaluation of Its Cytotoxic Activity.

Authors:  Dawid Lewandowski; Piotr Ruszkowski; Anita Pińska; Grzegorz Schroeder; Joanna Kurczewska
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

9.  Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells.

Authors:  Amit Wani; Galbokka H Layan Savithra; Ayat Abyad; Shrey Kanvinde; Jing Li; Stephanie Brock; David Oupický
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

10.  Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.

Authors:  Khaled AbouAitah; Anna Swiderska-Sroda; Ahmed A Farghali; Jacek Wojnarowicz; Agata Stefanek; Stanislaw Gierlotka; Agnieszka Opalinska; Abdou K Allayeh; Tomasz Ciach; Witold Lojkowski
Journal:  Oncotarget       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.